Officials did not disclose the contract value, however noted that
Jacobs is leading the project execution activities from its office in Singapore supported by work share from its other offices in the region.
Evonik is investing a total of approximately $636.5 million (€500 million) in the new production plant, which is planned to produce 150,000 metric tons per annum of amino acid DL-methionine, together with all the strategically important intermediates.
The integrated complex is scheduled for a 2014 start up. This increased capacity further consolidates Evonik’s market leadership in the core business of methionine, which is in high demand in the animal feed industry.
Evonik is one of the world’s largest specialty chemicals companies. It has production facilities in 28 countries. DL-methionine is an essential amino acid for healthy and environmentally-sustainable nutrition of farm animals.
Jacobs is one of the world’s largest and most diverse providers of technical, professional, and construction services.